ALKS
Alkermes plc Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Alkermes plc (ALKS) closed at $28.15 as of 2026-03-20, trading 0.1% below its 200-week moving average of $28.17. This places ALKS in the below line zone. The stock moved further from the line this week, up from -1.5% last week. The 14-week RSI sits at 49, indicating neutral momentum.
Trading volume is running at 1.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.12 ratio) is neutral — neither side is clearly dominating.
Over the past 1761 weeks of data, ALKS has crossed below its 200-week moving average 33 times. On average, these episodes lasted 24 weeks. Historically, investors who bought ALKS at the start of these episodes saw an average one-year return of +11.3%.
With a market cap of $4.7 billion, ALKS is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at 14.7%. The stock trades at 2.6x book value.
Over the past 33.2 years, a hypothetical investment of $100 in ALKS would have grown to $626, compared to $2683 for the S&P 500. ALKS has returned 5.7% annualized vs 10.4% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ALKS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ALKS Crosses Below the Line?
Across 32 historical episodes, buying ALKS when it crossed below its 200-week moving average produced an average return of +7.9% after 12 months (median +7.0%), compared to +5.9% for the S&P 500 over the same periods. 52% of those episodes were profitable after one year. After 24 months, the average return was +33.3% vs +11.2% for the index.
Each line shows $100 invested at the moment ALKS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ALKS has crossed below its 200-week MA 33 times with an average 1-year return of +11.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 1992 | Dec 1995 | 182 | 77.4% | -18.9% | +508.6% |
| Aug 1998 | Sep 1998 | 4 | 12.8% | +203.1% | +369.2% |
| Oct 1998 | Oct 1998 | 2 | 10.8% | +204.1% | +359.6% |
| Sep 2001 | Oct 2001 | 5 | 22.5% | -57.7% | +56.0% |
| Dec 2001 | Dec 2001 | 1 | 0.7% | -71.6% | +17.7% |
| Apr 2002 | Jul 2005 | 170 | 84.5% | -57.7% | +28.0% |
| Sep 2006 | Sep 2006 | 1 | 7.3% | +28.9% | +113.6% |
| Dec 2006 | Jan 2007 | 4 | 9.5% | +4.2% | +99.4% |
| Jan 2007 | Feb 2007 | 1 | 0.8% | -7.5% | +90.1% |
| Mar 2007 | Mar 2007 | 1 | 0.5% | -26.1% | +87.0% |
| Jun 2007 | Jul 2007 | 8 | 6.9% | -16.0% | +88.0% |
| Oct 2007 | Dec 2007 | 7 | 15.1% | -30.4% | +98.4% |
| Dec 2007 | Aug 2008 | 31 | 28.9% | -27.6% | +90.3% |
| Aug 2008 | Mar 2010 | 84 | 59.1% | -30.5% | +87.9% |
| May 2010 | Jul 2010 | 10 | 15.8% | +24.7% | +142.7% |
| Oct 2010 | Jan 2011 | 11 | 14.8% | +55.1% | +154.3% |
| Mar 2011 | Mar 2011 | 1 | 0.2% | +35.7% | +131.9% |
| Jan 2016 | May 2016 | 18 | 29.7% | +54.8% | -22.2% |
| Jun 2016 | Jun 2016 | 3 | 6.9% | +44.6% | -34.0% |
| Aug 2016 | Sep 2016 | 4 | 2.9% | +14.7% | -36.6% |
| Oct 2016 | Oct 2016 | 2 | 9.5% | +12.7% | -38.4% |
| Aug 2017 | Dec 2017 | 20 | 11.0% | -15.2% | -45.8% |
| Feb 2018 | Feb 2018 | 1 | 0.7% | -42.8% | -47.8% |
| Apr 2018 | Aug 2021 | 176 | 68.0% | -11.9% | -33.3% |
| Nov 2021 | Mar 2022 | 18 | 20.6% | -1.6% | +17.4% |
| Sep 2022 | Oct 2022 | 6 | 5.3% | +26.7% | +20.5% |
| Oct 2023 | Nov 2023 | 3 | 0.8% | +9.2% | +17.8% |
| Apr 2024 | Jul 2024 | 15 | 7.7% | +10.6% | +15.3% |
| Oct 2024 | Oct 2024 | 1 | 0.6% | +14.2% | +7.9% |
| Apr 2025 | Apr 2025 | 2 | 1.7% | N/A | +4.3% |
| Jul 2025 | Aug 2025 | 3 | 5.3% | N/A | +7.7% |
| Sep 2025 | Sep 2025 | 1 | 2.0% | N/A | +4.4% |
| Mar 2026 | Ongoing | 2+ | 1.5% | Ongoing | +1.4% |
| Average | 24 | — | +11.3% | — |
Frequently Asked Questions
Is ALKS below its 200-week moving average?
Yes. As of 2026-03-20, Alkermes plc (ALKS) is trading 0.1% below its 200-week moving average of $28.17. The current price is $28.15.
What is ALKS's 200-week moving average price?
Alkermes plc's 200-week moving average is $28.17 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ALKS drops below its 200-week moving average?
ALKS has crossed below its 200-week moving average 33 times in our data. On average, buying at that moment produced a one-year return of +11.3%. These dips have historically been decent entry points. These episodes lasted 24 weeks on average.
Is ALKS a good value right now?
Here's what our data says about ALKS as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 49. Free cash flow is currently negative. Return on equity is 14.7%. Price-to-book is 2.6x. This is not a buy or sell recommendation — always do your own research.
How does ALKS compare to the S&P 500?
Over the past 33.2 years, $100 invested in ALKS would have grown to $626, compared to $2683 for the S&P 500. That's 5.7% annualized vs 10.4% for the index. ALKS has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20